Cargando…
Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
OBJECTIVE: Patients with congenital adrenal hyperplasia due to P450 oxidoreductase (POR) deficiency (ORD) present with disordered sex development and glucocorticoid deficiency. This is due to disruption of electron transfer from mutant POR to microsomal cytochrome P450 (CYP) enzymes that play a key...
Autores principales: | Tomalik-Scharte, Dorota, Maiter, Dominique, Kirchheiner, Julia, Ivison, Hannah E, Fuhr, Uwe, Arlt, Wiebke |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioScientifica
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2977993/ https://www.ncbi.nlm.nih.gov/pubmed/20844025 http://dx.doi.org/10.1530/EJE-10-0764 |
Ejemplares similares
-
Prenatal Diagnosis of Congenital Adrenal Hyperplasia Caused by P450 Oxidoreductase Deficiency
por: Reisch, Nicole, et al.
Publicado: (2013) -
Pubertal Presentation in Seven Patients with Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
por: Idkowiak, Jan, et al.
Publicado: (2011) -
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
por: Krone, Nils, et al.
Publicado: (2012) -
Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
por: Zhang, Jin, et al.
Publicado: (2022) -
Long-term follow-up of a female with congenital adrenal hyperplasia due to P450-oxidoreductase deficiency
por: Bonamichi, Beatriz D. S. F., et al.
Publicado: (2016)